Listen to this article.
Camber announced the addition of 10 new generic medications to its portfolio during the third quarter of 2025. These launches, combined with the company’s growing Specialty Generics and OTC product lines, keep Camber on track to introduce nearly 60 new products this year—one of the most ambitious pipelines in the industry.
“Camber’s mission is to expand access to high-quality, affordable medicines,” said Kon Ostaficiuk, President of Camber Pharmaceuticals. “With one of the fastest-growing portfolios in the U.S. generic market, our focus remains on addressing critical therapeutic needs, ensuring supply continuity, and helping to lower the cost of healthcare for American patients and providers.”
Q3 2025 Launches
- Metformin HCl Oral Solution
- Sacubitril/Valsartan Tablets
- Amlodipine and Olmesartan Medoxomil Tablets
- Spironolactone Oral Suspension
- Magnesium Sulfate Injection
- Bexarotene Capsules
- Lubiprostone Capsules
- Darunavir Tablets
- Indomethacin Suppositories
- Voriconazole Injection
Building for the Future
Camber’s growth extends beyond product launches. In 2025, the company is on track to participate in over 50 conferences and industry events, thereby strengthening relationships with our distribution partners and key accounts. At NACDS TSE in San Diego this August, Camber hosted nearly 100 customer and partner meetings, underscoring its role as a trusted industry collaborator.
In addition, Camber is investing in infrastructure to support its expanding injectable portfolio. A new cold storage facility at the company’s Piscataway, NJ headquarters is nearing completion, which will significantly increase capacity and help ensure a reliable supply for hospitals and clinics nationwide.
Looking ahead, Camber anticipates launching at least 60 additional products in 2026, spanning generics, specialty generics, and OTC medicines. The company also plans to file 50+ new ANDA submissions in 2026, reinforcing its long-term commitment to providing reliable, cost-effective therapies across a wide range of therapeutic areas.
Contact your Camber representative to learn more about these launches and our complete product pipeline.
